Director – External Scientific Society Engagement
Revolution Medicines
Director – External Scientific Society Engagement
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Director will establish and lead Revolution Medicines' external scientific society engagement strategy, developing trusted partnerships across professional societies, community oncology networks, and research foundations. Through these relationships, the role will create a continuous exchange of scientific and healthcare ecosystem insights that informs evidence generation, medical strategy, clinical development, and commercial planning throughout the product lifecycle.
Develop and execute Revolution Medicines' external scientific engagement strategy, establishing long-term partnerships with professional societies, research foundations, and community oncology stakeholders.
Lead strategic engagement with global and national oncology societies to strengthen scientific collaboration, identify emerging opportunities, and enhance the company's external scientific presence.
Build and maintain relationships with scientific leaders, young investigators, and key external stakeholders to foster innovation, advance research collaborations, and support the future oncology community.
Generate and synthesize scientific, clinical, and healthcare ecosystem insights from external engagements, translating them into actionable recommendations that inform Medical Affairs, Clinical Development, evidence generation, and commercial strategy.
Partner cross-functionally with Medical Affairs, Clinical Development, Translational Medicine, Research, Medical Communications, HEOR, Market Access, Commercial, and Field Medical teams to align external engagement strategies with enterprise priorities.
Represent Revolution Medicines with scientific credibility and integrity in interactions with professional societies, research foundations, and external scientific organizations while ensuring compliance with applicable legal and regulatory requirements.
Required Skills, Experience and Education:
12+ years of progressive experience in the oncology biopharmaceutical industry, with significant experience in Medical Affairs, Clinical Development, Scientific Strategy, External Engagement, or related functions.
Demonstrated success developing and leading external scientific engagement strategies with professional medical societies, research foundations, academic organizations, and oncology networks.
Deep understanding of the oncology landscape, including scientific exchange, evidence generation, clinical research, and evolving standards of care.
Experience translating external scientific and healthcare ecosystem insights into strategic recommendations that influence portfolio, evidence generation, and commercialization decisions.
Proven ability to build trusted relationships with key opinion leaders (KOLs), society leadership, investigators, and external stakeholders across academic and community oncology settings.
Strong cross-functional leadership experience collaborating with Medical Affairs, Clinical Development, Translational Medicine, Research, Commercial, Market Access, HEOR, and Medical Communications.
Experience representing an organization at major scientific congresses, advisory activities, and professional society meetings.
Demonstrated ability to lead complex, cross-functional initiatives in a fast-paced, matrixed organization.
Strong understanding of applicable healthcare compliance, legal, and regulatory requirements governing scientific exchange and external engagement.
Advanced scientific degree preferred (PharmD, PhD, NP).
Preferred Skills:
Experience in precision oncology or targeted therapies.
Experience with global product launches including support of launch planning.
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 201000 - 251000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines